Cancer cell-derived xenograft model (CDX) in mouse
According to the request of our customer (markets), CIR Biopharma can provide various subcutaneous xenograft tumor models constructed from human-derived tumor cell lines in immunodeficient mice for evaluating the effectiveness of drugs. The tumor types cover: lung cancer, breast cancer, gastric cancer, liver cancer, pancreatic cancer, cervical cancer, ovarian cancer and so on. At the same time, the team has completed testing of standard treatment regimens in the relevant models to evaluate the response to positive control drugs. CIR Biopharma can help clients choose targeted models for their different needs. We are committed to providing timely and efficient pharmacodynamic evaluation services with high standards and quality.